CTOs on the Move

Humacyte

www.humacyte.com

 
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.humacyte.com
  • 2525 E NC Highway 54
    Durham, NC USA 27713
  • Phone: 919.313.9633

Executives

Name Title Contact Details
Heather Prichard
 Chief Operating Officer Profile

Funding

Humacyte raised $150M on 10/20/2015
Humacyte raised $18M on 10/02/2017
Humacyte raised $150M on 06/11/2018
Humacyte raised $50M on 04/14/2021
Humacyte raised $38M on 04/14/2021

Similar Companies

Dadson Manufacturing

Dadson Manufacturing, Inc. is a Grain Valley, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EMQ FamiliesFirst

EMQ FamiliesFirst is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Bio Facilities Associates

Pacific Bio Facilities Associates is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Universal Endoscopic Svc Inc

Universal Endoscopic Svc Inc is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedMen

MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations nationwide. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market. Based in Los Angeles, MedMen employs over 1,100 team members across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to redefine our society`s relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens. MedMen supports sensible, clear and just drug laws that strengthen communities and create economic opportunities. The company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates.